Aortic valve replacement in patients with previous coronary artery bypass grafting: 10-year experience
Authors:
Open Access
- 26 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 41 (3) , e1-e6
Abstract
This study aimed to investigate the early and late outcomes of patients undergoing aortic valve replacement (AVR) with previous coronary artery bypass grafting (CABG) and patent grafts. Between January 2000 and March 2010, 104 patients (87 males) with previous CABG ± concomitant surgery and patent grafts underwent AVR. The median age of the patients was 75 years (range: 37–90 years; inter-quartile range: 69–79 years) and the mean logistic EuroScore was 25.37 ± 16.8. The median time since the previous operation was 9 years (range 1–25; inter-quartile range: 7–14 years). The left internal mammary artery (LIMA) had been used in 75 patients (72.1%) and remained patent in 72 cases (96.0%). Thirty-day mortality was 7.7% (n = 8), which is less than the predicted mean logistic EuroScore. Isolated AVR was performed in 66 patients (63.5%). The LIMA was dissected and isolated (clamped or blocked with balloon) in 60 patients. The median hospital stay was 10 days (range: 4–183 days; inter-quartile range: 7–15.25 days). Nineteen patients (18.3%) had pulmonary complications, while 12 (11.5%) had acute kidney injury. Seven patients (6.7%) required permanent pacemaker. Six LIMAs (8.3%) were injured and repaired. Prolonged aortic cross-clamp (AXC) time (P = 0.038) and the presence of a previous LIMA graft (P = 0.045) were identified as independent predictors of 30-day mortality. The actuarial survival at 1 and 5 years was 89.4 ± 0.3 and 81.5 ± 0.5%, respectively. Perioperative intra-aortic balloon pump use (P = 0.036), prolonged AXC time (P = 0.004) and prolonged cardiopulmonary bypass time (P = 0.022) were associated with worse long-term overall survival on multivariate analysis. AVR post-CABG with patent grafts can be performed in high-risk patients with excellent short- and long-term outcomes and appears to be superior to published catheter-based interventions. In the absence of randomized trial data, we believe that open AVR remains the treatment of choice for aortic valve disease following prior CABG.Keywords
This publication has 15 references indexed in Scilit:
- Interstitial Lung Disease and GefitinibNew England Journal of Medicine, 2010
- Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement?The Journal of Thoracic and Cardiovascular Surgery, 2008
- Aortic valve replacement following previous coronary surgeryEuropean Journal of Cardio-Thoracic Surgery, 2005
- Supraclavicular control of patent internal thoracic artery graft flow during aortic valve replacementThe Annals of Thoracic Surgery, 2003
- Aortic valve replacement after previous coronary artery bypass graftingThe Annals of Thoracic Surgery, 1996
- Safety of remote aortic valve replacement after prior coronary artery bypass graftingThe Annals of Thoracic Surgery, 1996
- Management of Mild Aortic Stenosis During Coronary Artery Bypass Graft SurgeryJournal of Cardiac Surgery, 1994
- Technical Considerations for Myocardial Protection during the Course of Coronary Artery Bypass Reoperation: The Impact of Functioning Saphenous Vein and Internal Mammary Artery GraftsJournal of Cardiac Surgery, 1991
- Coronary artery reoperations: Early and Late Results in 101 PatientsScandinavian Journal of Thoracic and Cardiovascular Surgery, 1988
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986